MEAPT VC Trends in March 2025: Rebounding Investments and Shifting Dynamics

The venture capital landscape across the Middle East, Africa, Pakistan, and Turkey (MEAPT) has seen a rollercoaster of fluctuations in VC investment figures over the past few years. March marks the third consecutive month where 2024 year-to-date (YTD) total deal value lagged behind 2023 levels, only to be surpassed by 2025 totals—a pattern that has been visible across the entire first quarter of 2025. In 2023, MEAPT VC funding had reached a YTD total deal value of US $3.29 billion by March. That momentum faltered significantly in 2024, with YTD values plunging by 29.3% to just US $2.326 billion. As of March 2025, however, the region has rebounded with US $2.756 billion in VC funding—up 18.5% compared to the same period in 2024. Though funding was up this month compared to the same time last year, March 2025 saw no funding rounds at or greater than US $100 million, a sharp contrast to March 2024, which featured 4 mega-rounds, and March 202,3 which also witnessed 2 mega-rounds. 

Deal count, on the other hand, tells a different story. While total funding value has started to bounce back in 2025, the number of deals has continued to decline steadily year-over-year. This marks the third month in a row—January, February, and now March—where deal volume has dropped year over year, going from 712 in March 2023, to 568 in March 2024, and now down to 266 in March 2025. As a result, average deal size has risen significantly: from approximately US $4 million in March 2023 and March 2024, before surging to over US $10 million by March 2025.  

While deal volume remains low, this strategic influx of capital and international exposure is contributing to the concentration of larger, high-value deals in 2025. Analysts suggest that this trend may be supported by improving global macroeconomic conditions, including declining interest rates and easing inflation, which could help stabilize investor risk appetite. The early signs of a selective VC funding resurgence in MEAPT appear to reflect this shift—where investors are returning, but with sharper focus and higher standards. As we continue to monitor VC activity in the months ahead, we wait to see whether this trend evolves into a sustained recovery for the MEAPT region.  

Top 10 Funding Rounds of March 2025

• OSN+ (UAE): raised US $57 million in a corporate round led by Warner Bros Discovery (30 % stake).
• Kela Technologies (Israel): raised US $39 million across a Series A led by Lux Capital (US $28 m) and a Seed led by Sequoia Capital (US $11 m).
• Grain (Israel): raised US $33 million in a Series A round led by Bain Capital Ventures.
• NymCard (UAE): raised US $33 million in a Series B round led by QED Investors.
• Nurami Medical (Israel): raised US $30 million in a funding round led by Ribbit Capital.
• Sola Security (Israel): raised US $30 million in a Seed round led by S Capital with participation from Mike Moritz.
• Aleph Farms (Israel): raised US $29 million in a venture round (SAFE) from existing investors (names undisclosed).
• Klaim (UAE): raised US $26 million through a Series A equity round led by CDG Invest and Mad'a Investment Company, plus a debt facility led by Tharawat Holding.
• Utila (Israel): raised US $18 million in a Series A round led by Nyca Partners.
• Brain.space (Israel): raised US $11 million in a Series A round led by Toyota Ventures.